Harvard Medical School Faculty Advances Drug Safety Research with IBM Business Analytics
IBM (NYSE: IBM) announced that faculty from Harvard Medical School and Brigham & Women's Hospital will use IBM business analytics technology at the core of new research that examines the effectiveness of prescription drugs and spots potential safety issues.
Read more ...
New potential drug targets discovered for preventing prostate cancer cell growth
Researchers from VTT Technical Research Centre of Finland and the University of Turku have discovered four metabolic enzymes regulating prostate cancer cell growth. Inhibition of these enzymes prevents prostate cancer cell growth in cultured cells.
Read more ...